優盛

+0.05 (+0.40%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

12.7020成交張數–本益比0.74股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	40	14	52.3%	1.95	16.56	-2.9%	-1.0%	1.0	0.9
2026Q1	41	14	52.6%	1.97	16.81	-2.0%	-0.7%	0.4	0.3
2025Q4	42	14	52.9%	1.92	17.04	-2.1%	-0.7%	0.9	0.7
2025Q3	41	14	51.9%	2.02	16.99	-2.5%	-0.9%	0.5	0.4
2025Q2	41	14	51.1%	2.02	16.71	-2.8%	-1.0%	1.0	0.9
2025Q1	42	15	50.4%	2.10	17.33	-2.9%	-1.0%	0.5	0.4
2024Q4	42	15	50.6%	2.04	17.36	-2.0%	-0.7%	1.7	1.5
2024Q3	43	15	50.5%	2.09	17.72	-2.3%	-0.8%	0.8	0.7
2024Q2	44	15	52.2%	1.93	17.60	-1.2%	-0.4%	0.1	-0.1
2024Q1	46	16	52.0%	1.94	18.30	-0.8%	-0.3%	0.6	0.4
2023Q4	41	14	54.7%	1.73	17.00	-0.4%	-0.2%	0.6	0.4
2023Q3	40	15	53.7%	1.77	17.24	2.4%	0.9%	1.3	1.1
2023Q2	40	14	53.1%	1.80	17.07	5.4%	1.9%	1.4	1.1
2023Q1	41	16	52.3%	1.86	18.44	10.6%	4.0%	-0.3	-0.6
2022Q4	40	16	51.3%	1.87	18.28	11.4%	4.4%	1.7	1.4
2022Q3	41	15	54.0%	1.76	17.89	10.2%	3.9%	0.8	0.5
2022Q2	42	15	56.3%	1.66	17.27	8.0%	3.0%	1.9	1.6
2022Q1	39	15	53.7%	1.80	17.48	7.3%	2.7%	-0.1	-0.5
2021Q4	38	14	52.6%	1.87	17.14	8.0%	3.1%	2.0	1.5
2021Q3	36	14	50.8%	2.02	17.07	10.7%	4.2%	0.8	0.7
2021Q2	38	15	51.1%	2.03	18.03	13.8%	5.2%	1.4	1.2
2021Q1	36	14	53.6%	2.06	17.21	11.5%	4.2%	1.6	-1.0
2020Q4	34	13	50.5%	2.20	16.91	11.0%	4.2%	0.8	0.7
2020Q3	32	12	55.0%	1.91	16.42	9.8%	3.7%	-3.1	-3.3
2020Q2	33	11	58.7%	1.78	15.59	5.4%	1.9%	6.2	6.1
2020Q1	32	11	58.1%	2.08	15.49	3.5%	1.3%	0.7	0.4
2019Q4	31	11	56.5%	2.17	15.27	2.3%	1.0%	0.9	0.8
2019Q3	30	11	56.2%	2.30	15.15	1.1%	0.4%	-1.3	-1.4
2019Q2	31	11	56.5%	2.30	15.20	1.2%	0.5%	1.3	1.2
2019Q1	29	11	54.2%	2.05	15.24	1.9%	0.8%	-0.2	-0.2
2018Q4	23	11	41.7%	2.46	15.30	1.5%	0.7%	-0.1	-0.3
2018Q3	23	11	41.3%	2.58	15.37	2.4%	1.1%	-0.5	-0.6
2018Q2	24	11	44.0%	2.35	15.39	4.3%	2.1%	1.2	1.2
2018Q1	23	11	42.3%	2.54	15.56	5.2%	2.5%	-0.4	-0.5
2017Q4	24	11	43.9%	2.44	15.50	2.5%	1.2%	0.5	0.4
2017Q3	24	11	44.7%	2.42	15.38	6.2%	2.7%	-1.5	-1.6
2017Q2	22	11	40.6%	2.10	14.97	3.2%	1.5%	0.3	0.3
2017Q1	22	11	40.8%	2.17	14.63	-0.3%	-0.1%	-0.2	-0.4
2016Q4	22	11	39.3%	2.08	15.16	–	–	0.3	0.1
2016Q3	25	11	47.4%	1.86	14.56	–	–	-0.4	-0.6